Oncology nurses can help patients understand this novel mechanism of action and its potential as a treatment option.

Liminatus Pharma is a preclinical oncology company focused on a CD47 antibody. Check out why I see little reason for ...

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies for infectious diseases and cancer, today commented on the U.S. Food and ...

Part 1 (SAD) was a single ascending dose study that evaluated five TERN-601 dose levels in healthy participants with a Body Mass Index (BMI) of = 25 kg/m 2 and < 40 kg/m 2. The starting TERN-601 dose ...

PCP2, can effectively measure PD-L1 expression in patients with head and neck cancers, outperforming the conventional tracer ...

New trial results reveal zanzalintinib and atezolizumab significantly enhance survival in metastatic colorectal cancer, ...

Innovent Biologics is pivoting to R&D and oncology growth in China, but high valuation and risks temper upside. Read why ...

New research has uncovered immune changes in cancer patients that could help identify which patients are most at risk of dangerous heart complications ...

New trial data reveals atebimetinib combined with gemcitabine/nab-paclitaxel significantly improves survival rates in ...

(NYSE American: MAIA), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, ...

Like PD-1 inhibitors, DLL3-targeted therapies face intrinsic resistance driven by MHC-I loss and terminally exhausted T-cell states. Preclinical data suggest that DLL3High/PD-L1High tumors amplify ...